297 related articles for article (PubMed ID: 30481277)
21. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
22. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice.
Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152
[TBL] [Abstract][Full Text] [Related]
23. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
24. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome.
Zoukhri D; Hodges RR; Rawe IM; Dartt DA
Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115
[TBL] [Abstract][Full Text] [Related]
25. Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice?
Rahimi Darabad R; Suzuki T; Richards SM; Jakobiec FA; Zakka FR; Barabino S; Sullivan DA
Exp Eye Res; 2014 Oct; 127():153-60. PubMed ID: 25084452
[TBL] [Abstract][Full Text] [Related]
26. BXSB/MpJ-Yaa mice develop autoimmune dacryoadenitis with the appearance of inflammatory cell marker messenger RNAs in the lacrimal fluid.
Kosenda K; Ichii O; Otsuka S; Hashimoto Y; Kon Y
Clin Exp Ophthalmol; 2013 Nov; 41(8):788-97. PubMed ID: 23433092
[TBL] [Abstract][Full Text] [Related]
27. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
28. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Meyerholz DK; Lieberman SM
Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
[TBL] [Abstract][Full Text] [Related]
29. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
Trune DR; Leedy DA
Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
Ono M; Rocha FJ; Sullivan DA
Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
[TBL] [Abstract][Full Text] [Related]
31. Salivary and Lacrimal Gland Alterations of the Epidermal Fatty Acid-Binding Protein (E-FABP) in Non-Obese Diabetic Mice.
Dogru M; Kojima T; Simsek C; Nagata T; Tsubota K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408851
[TBL] [Abstract][Full Text] [Related]
32. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
Sato EH; Sullivan DA
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
[TBL] [Abstract][Full Text] [Related]
33. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
Sato EH; Ariga H; Sullivan DA
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis.
Azuma T; Takei M; Yoshikawa T; Nagasugi Y; Kato M; Otsuka M; Shiraiwa H; Sugano S; Mitamura K; Sawada S; Masuho Y; Seki N
Immunol Lett; 2002 May; 81(3):171-6. PubMed ID: 11947921
[TBL] [Abstract][Full Text] [Related]
35. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
36. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
38. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
[TBL] [Abstract][Full Text] [Related]
39. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
40. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
da Costa SR; Wu K; Veigh MM; Pidgeon M; Ding C; Schechter JE; Hamm-Alvarez SF
Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
